PROVENTION BIO INC's ticker is PRVB and the CUSIP is 74374N102. A total of 185 filers reported holding PROVENTION BIO INC in Q1 2023. The put-call ratio across all filers is 1.57 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $991,715 | -82.5% | 41,150 | -92.3% | 0.00% | -100.0% |
| Q4 2022 | $5,653,534 | +4650.9% | 534,866 | +1920.4% | 0.00% | – |
| Q3 2022 | $119,000 | +26.6% | 26,473 | +13.0% | 0.00% | – |
| Q2 2022 | $94,000 | -94.3% | 23,419 | -89.7% | 0.00% | – |
| Q1 2022 | $1,659,000 | +1282.5% | 226,708 | +967.2% | 0.00% | – |
| Q4 2021 | $120,000 | -23.6% | 21,244 | -13.8% | 0.00% | – |
| Q3 2021 | $157,000 | -16.9% | 24,658 | +10.4% | 0.00% | – |
| Q2 2021 | $189,000 | +23.5% | 22,345 | +53.3% | 0.00% | – |
| Q1 2021 | $153,000 | -97.4% | 14,576 | -95.7% | 0.00% | -100.0% |
| Q4 2020 | $5,790,000 | +24.4% | 341,823 | -5.8% | 0.00% | 0.0% |
| Q3 2020 | $4,653,000 | -21.8% | 362,703 | -14.0% | 0.00% | 0.0% |
| Q2 2020 | $5,949,000 | +27.4% | 421,619 | -16.9% | 0.00% | 0.0% |
| Q1 2020 | $4,669,000 | +104.9% | 507,485 | +231.8% | 0.00% | +100.0% |
| Q4 2019 | $2,279,000 | – | 152,962 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MORGAN JESS S & CO INC | 217,050 | $2,278,000 | 1.60% |
| Perceptive Advisors | 2,852,058 | $29,932,000 | 0.38% |
| 683 Capital Management, LLC | 630,000 | $6,612,000 | 0.35% |
| ADVISORY RESEARCH INC | 237,500 | $2,493,000 | 0.18% |
| GILDER GAGNON HOWE & CO LLC | 3,109,874 | $32,638,000 | 0.18% |
| RICE HALL JAMES & ASSOCIATES, LLC | 247,195 | $2,594,000 | 0.08% |
| Virtus ETF Advisers LLC | 16,158 | $170,000 | 0.07% |
| Walleye Capital LLC | 103,823 | $1,090,000 | 0.06% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 22,755 | $239,000 | 0.05% |
| GSA CAPITAL PARTNERS LLP | 29,384 | $308,000 | 0.05% |